- Home
- LNT vs ZBH Comparison
LNT vs ZBH Comparison
Compare LNT & ZBH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNT | ZBH |
|---|---|---|
| Founded | 1917 | 1927 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Industrial Specialties |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 19.9B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LNT | ZBH |
|---|---|---|
| Price | $65.52 | $94.23 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 19 |
| Target Price | $69.38 | ★ $108.56 |
| AVG Volume (30 Days) | 2.1M | ★ 2.1M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | ★ 3.10% | 1.02% |
| EPS Growth | ★ 23.58 | N/A |
| EPS | 3.18 | ★ 4.03 |
| Revenue | $4,274,000,000.00 | ★ $8,010,900,000.00 |
| Revenue This Year | $7.01 | $8.20 |
| Revenue Next Year | $4.72 | $5.92 |
| P/E Ratio | ★ $20.59 | $23.38 |
| Revenue Growth | ★ 7.77 | 5.47 |
| 52 Week Low | $56.30 | $85.33 |
| 52 Week High | $69.75 | $114.44 |
Technical Indicators
Market Signals| Indicator | LNT | ZBH |
|---|---|---|
| Relative Strength Index (RSI) | 36.28 | 49.85 |
| Support Level | $67.10 | $92.14 |
| Resistance Level | $69.50 | $98.34 |
| Average True Range (ATR) | 0.95 | 1.99 |
| MACD | -0.32 | 0.49 |
| Stochastic Oscillator | 6.35 | 58.27 |
Price Performance
Historical ComparisonAbout LNT Alliant Energy Corporation
Alliant Energy is the parent of two regulated utilities, Interstate Power and Light and Wisconsin Power and Light. Together, IPL and WPL serve nearly 1 million electric customers and 425,000 natural gas-only customers. Both subsidiaries engage in the generation and distribution of electricity and the distribution and transportation of natural gas. Alliant also owns a 16% interest in American Transmission Co.
About ZBH Zimmer Biomet Holdings Inc.
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two-thirds of total revenue is derived from sales of large joints; another fourth comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.